Li, Edmond
Lounsbury, Olivia
Clarke, Jonathan
Ashrafian, Hutan
Darzi, Ara
Neves, Ana Luisa
Funding for this research was provided by:
Patient Safety Translational Research Centre (PSTRC-2016-004, PSTRC-2016-004, PSTRC-2016-004, PSTRC-2016-004)
Article History
Received: 12 December 2022
Accepted: 2 August 2023
First Online: 12 August 2023
Declarations
:
: Overall ethical approval for this project was granted by the Imperial College Research Ethics Committee (ICREC) (Reference 20IC5906). This is a dedicated ethics oversight body at Imperial College London for all health-related research involving human participants. Whenever necessary, local ethical approval and relevant permissions were also obtained. All participants provided written informed consent prior to participating in the study and consented to their interviews being recorded. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: HA is chief scientific officer of Preemptive Health and Medicine at Flagship Pioneering. AD is executive chair of Preemptive Health and Medicine at Flagship Pioneering. All other authors do not have any competing interests.